Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Celldex Therapeutics (CLDX)

0.7261 -0.064 (-8.1%)

04-18 16:00

Open:

0.802

Pre. Close:

0.7901

High:

0.8065

Low:

0.72

Volume:

10,268,116

Market Cap:

102M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.811 - 0.815

0.815 - 0.819

Low:

0.709 - 0.714

0.714 - 0.718

Close:

0.722 - 0.729

0.729 - 0.736

Technical analysis  (as of: 2018-04-18 4:39:04 PM)

Overall:

      

Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 2.25     One year: 3.12

Support:

Support1: 0.72    Support2: 0.60

Resistance:

Resistance1: 1.93    Resistance2: 2.67

Pivot:

1.87

Moving Averages:

MA(5): 1.33     MA(20): 2.01

MA(100): 2.57     MA(250): 2.65

MACD:

MACD(12,26): -0.34     Signal(12,26,9): -0.18

%K %D:

%K(14,3): 0.71     %D(3): 14.04

RSI:

RSI(14): 17.55

52-Week:

High: 3.42  Low: 0.72  Change(%): -77.7

Average Vol(K):

3-Month: 221151  10-Days 586743

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CLDX has closed below the lower band by 0.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 392.1% wider than normal. The large width of the bands suggest high volatility as compared to CLDX's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

2018-04-18T13:54:41-04:00
OncoSec: The Underlying Science Of ImmunoPulse Powers A Potential Winner

2018-04-18T11:55:19-04:00
Celldex Tumbles On Phase 2 Trial Failure; Is There Any Value Left?

2018-04-17T02:29:11-04:00
Rounds Report: Regenxbio Surged Higher While Celldex Tumbled Due To A Negative Clinical Binary

2018-04-17T02:14:33-04:00
Biotech Analysis Central Pharma News: GlaxoSmithKline Passes Along Pipeline, Pulse Impresses, Celldex's Failure

2018-04-16T12:40:56-04:00
Midday Gainers / Losers (04/16/2018)

2018-04-16T09:13:58-04:00
Premarket Losers as of 9:05 am (4/16/2018)

2018-04-16T08:27:33-04:00
Celldex's lead candidate flunks breast cancer study; shares down 51% premarket

2018-04-01T06:20:10-04:00
Cancer Vaccine With 97% Complete Response Rate In Mice Starts Human Trials

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

141.07

Shares Float (M)

134.45

% Held by Insiders

4.70

% Held by Institutions

50.70

Shares Short (K)

9103

Shares Short Prior Month (K)

7410

Stock Financials

EPS

-0.820

EPS Est. Current Year

-1.040

EPS Est. Next Year

-0.950

EPS Est. Next Quarter

-0.280

Forward EPS

-0.739

Book Value (p.s.)

1.280

PEG Ratio

Profit Margin

Operating Margin

-857.94

Return on Assets (ttm)

-26.6

Return on Equity (ttm)

-37.1

Qtrly Rev. Growth

84.5

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.652

Qtrly Earnings Growth

Operating Cash Flow (M)

-99.93

Levered Free Cash Flow (M)

-59.52

atoplab.com

Valuation

P/E

-0.89

P/E Growth Ratio

-0.08

P/BV

0.57

P/S

1024309248.00

P/CF

-1.03

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.